Exchange Traded Concepts, LLC Gilead Sciences, Inc. Transaction History

Exchange Traded Concepts, LLC

$4.18 Billion
Q3 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 245,817 shares of GILD stock, worth $22.2 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

245,817

Previous 9,516 2483.2%

Holding current value

$22.2 Million

Previous $652,000 3060.12%

% of portfolio

0.49%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$66.59 - $83.99 $15.7 Million - $19.8 Million	236,301 Added 2483.2%	245,817 $20.6 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $14 Million - $16.2 Million	-221,635 Reduced 95.88%	9,516 $652,000
Q1 2024 Apr 15, 2024	BUY	$71.58 - $87.29 $2.45 Million - $2.99 Million	34,267 Added 17.4%	231,151 $16.9 Million
Q4 2023 Jan 05, 2024	BUY	$73.27 - $83.09 $328,762 - $372,824	4,487 Added 2.33%	196,884 $15.9 Million
Q3 2023 Oct 18, 2023	SELL	$73.94 - $80.67 $8.72 Million - $9.52 Million	-117,972 Reduced 38.01%	192,397 $14.4 Million
Q2 2023 Jul 20, 2023	BUY	$76.01 - $86.7 $10.1 Million - $11.5 Million	132,964 Added 74.95%	310,369 $23.9 Million
Q1 2023 Apr 12, 2023	SELL	$77.31 - $88.08 $1.11 Million - $1.26 Million	-14,321 Reduced 7.47%	177,405 $14.7 Million
Q4 2022 Jan 17, 2023	SELL	$62.32 - $89.47 $5.1 Million - $7.33 Million	-81,886 Reduced 29.93%	191,726 $16.5 Million
Q3 2022 Oct 07, 2022	SELL	$59.54 - $68.01 $272,216 - $310,941	-4,572 Reduced 1.64%	273,612 $16.9 Million
Q2 2022 Jul 20, 2022	SELL	$57.72 - $65.01 $252,409 - $284,288	-4,373 Reduced 1.55%	278,184 $17.2 Million
Q1 2022 Apr 26, 2022	BUY	$57.92 - $72.58 $2.98 Million - $3.74 Million	51,519 Added 22.3%	282,557 $16.8 Million
Q4 2021 Jan 13, 2022	BUY	$64.88 - $73.64 $374,033 - $424,534	5,765 Added 2.56%	231,038 $16.8 Million
Q3 2021 Oct 18, 2021	BUY	$67.69 - $73.03 $11.7 Million - $12.6 Million	172,935 Added 330.42%	225,273 $15.7 Million
Q2 2021 Jul 30, 2021	SELL	$63.47 - $69.35 $6.43 Million - $7.02 Million	-101,270 Reduced 65.93%	52,338 $3.6 Million
Q1 2021 Apr 20, 2021	BUY	$60.0 - $68.46 $329,160 - $375,571	5,486 Added 3.7%	153,608 $9.93 Million
Q4 2020 Jan 19, 2021	BUY	$56.65 - $64.55 $3.56 Million - $4.05 Million	62,799 Added 73.6%	148,122 $8.63 Million
Q3 2020 Oct 30, 2020	SELL	$62.1 - $78.08 $218,902 - $275,232	-3,525 Reduced 3.97%	85,323 $5.39 Million
Q2 2020 Jul 15, 2020	BUY	$72.34 - $84.0 $4.45 Million - $5.16 Million	61,484 Added 224.69%	88,848 $6.84 Million
Q1 2020 Apr 14, 2020	SELL	$62.63 - $80.22 $12.1 Million - $15.5 Million	-192,877 Reduced 87.58%	27,364 $2.05 Million
Q4 2019 Jan 22, 2020	BUY	$61.62 - $67.78 $13.6 Million - $14.9 Million	220,241 New	220,241 $14.3 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Gilead Sciences, Inc. Transaction History